Cathie Wood's Top and Bottom Performing ARKK Holdings of H1
Natera's New Cancer Trial to Use Signatera for Personalized Treatment
Express News | Natera Announces Decipher: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer
Natera(NTRA.US) Director Sells US$296.08K in Common Stock
$Natera(NTRA.US)$ Director Sheena Jonathan sold 2,700 shares of common stock on Jun 18, 2024 at an average price of $109.6591 for a total value of $296.08K.Source: Announcement What is statement of ch
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
Health Check: How Prudently Does Natera (NASDAQ:NTRA) Use Debt?
Insider Selling: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
Natera(NTRA.US) Officer Sells US$681.37K in Common Stock
$Natera(NTRA.US)$ Officer Chapman Steven Leonard sold 6,105 shares of common stock on Jun 17, 2024 at an average price of $111.6088 for a total value of $681.37K.Source: Announcement What is statement
Form 144 | Natera(NTRA.US) Officer Proposes to Sell 681.37K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 17, $Natera(NTRA.US)$ Officer STEVEN L CHAPMAN intends to sell 6,105 shares of its common stock on Jun 17, with a total market value of approximately $681.37K. STEVEN L C
Natera Launches Differentiated New Feature for Prospera Heart Test, Enhancing Detection of Rejection for Transplant Patients
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,400 Today
Amazon, Natera And A Financial Stock: CNBC's 'Final Trades'
U.S. stocks prospecting | Semiconductor stocks surge! Asml Holding rose 9%, Taiwan Semiconductor and Nvidia hit new highs; AI servers are hot, Hewlett Packard Enterprise rose more than 10%.
The biotechnology sector saw a stock rebound, among which Intuitive Surgical rose nearly 3%, Vertex Pharmaceuticals rose nearly 2%, and Regeneron Pharmaceuticals rose over 1%, all hitting a new high for the year.
Breaking Down Natera: 10 Analysts Share Their Views
Natera Price Target Announced at $142.00/Share by Jefferies
Natera Initiated at Buy by Jefferies
Express News | Natera (NTRA.US) has received its first coverage from Jefferies Financial banks, receiving a buy recommendation with a target price of $142 USD.
Jefferies Initiates Coverage On Natera With Buy Rating, Announces Price Target of $142
Natera Analyst Ratings
Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference